ID: ALA323355

Max Phase: Preclinical

Molecular Formula: C35H41N3O4

Molecular Weight: 567.73

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCCCC(NC(=O)c1ccc(C#N)cc1)C(C)(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1

Standard InChI:  InChI=1S/C35H41N3O4/c1-4-5-6-13-18-31(38-32(39)29-21-19-27(24-36)20-22-29)35(2,3)34(41)37-30(23-26-14-9-7-10-15-26)33(40)42-25-28-16-11-8-12-17-28/h7-12,14-17,19-22,30-31H,4-6,13,18,23,25H2,1-3H3,(H,37,41)(H,38,39)/t30-,31?/m0/s1

Standard InChI Key:  JOOSDCJBEPKADP-FSRLHOSWSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 567.73

Molecular Weight (Monoisotopic): 567.3097

AlogP: 6.12

#Rotatable Bonds: 15

Polar Surface Area: 108.29

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 12.25

CX Basic pKa:

CX LogP: 7.43

CX LogD: 7.43

Aromatic Rings: 3

Heavy Atoms: 42

QED Weighted: 0.17

Np Likeness Score: -0.40

References

1. Iijima K, Katada J, Yasuda E, Uno I, Hayashi Y..  (1999)  N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.,  42  (2): [PMID:9925737] [10.1021/jm980562h]

Source

Source(1):

• Scientific Literature